Annual report
9989.TEDINET S100YL7Q
Period2025-04-01 → 2026-03-31
Filed2026-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥842.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥801.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥751.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥690.5bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥46.8bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥44.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥46.2bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥43.8bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥41.7bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥38.1bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥45.8bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥43.6bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥31.4bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥30.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.1bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25.7bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥31.4bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥30.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥475.5bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥444.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥420.2bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥360.7bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥325.8bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥189.5bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥174.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥286.0bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥269.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥253.1bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥236.3bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥220.6bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥70.5bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥65.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥70.5bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥65.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥69.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.9bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥89.3bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥43.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥37.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥32.1bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥35.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥74.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥28.5bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥22.5bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥17.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥268.36 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.91 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥249.07 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥219.83 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥219.82 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥2,444.81 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,305.89 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,164.06 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,020.97 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,886.4 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 60.1% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.7% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.5% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 7,457 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 7,145 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 6,662 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 6,371 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 6,015 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥505.4bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥485.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥463.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥433.1bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥415.9bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥26.6bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥25.6bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥35.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥24.8bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥25.3bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.2bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥21.3bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥34.7bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥24.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥27.5bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥17.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥17.8bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥15.7bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥14.9bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥314.2bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥300.3bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥298.2bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥255.1bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥244.1bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥123.5bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥122.0bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥190.7bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥178.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥175.0bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥169.6bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥163.9bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥37.2bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥35.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥235.17 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥150.38 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.95 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.69 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥127.09 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥134.68 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥127.09 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥131 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥114 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥71 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,629.87 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,524.29 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,496.02 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,450.09 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,401.22 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 60.7% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.7% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.1% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.9% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.0% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 119,331,184 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,622 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 4,413 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 4,090 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 3,895 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 3,795 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 51
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥61.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥61.0bn |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | −¥26.5bn |
| Discount Storereportable segment | capex | 2025-04-01 → 2026-03-31 | ¥13.6bn |
| Discount Storereportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥6.8bn |
| Discount Storereportable segment | employees | at 2026-03-31 | 1880 pure |
| Discount Storereportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥364.1bn |
| Discount Storereportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥364.1bn |
| Discount Storereportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥13m |
| Discount Storereportable segment | segment assets | at 2026-03-31 | ¥169.6bn |
| Discount Storereportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥19.4bn |
| Drug Storereportable segment | capex | 2025-04-01 → 2026-03-31 | ¥16.3bn |
| Drug Storereportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥11.9bn |
| Drug Storereportable segment | employees | at 2026-03-31 | 5577 pure |
| Drug Storereportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥539.4bn |
| Drug Storereportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥478.4bn |
| Drug Storereportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥61.0bn |
| Drug Storereportable segment | segment assets | at 2026-03-31 | ¥332.4bn |
| Drug Storereportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥27.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥29.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥903.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥842.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥61.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥502.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥46.8bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥57.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥57.8bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | −¥25.5bn |
| Discount Storereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥14.6bn |
| Discount Storereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6.0bn |
| Discount Storereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥342.3bn |
| Discount Storereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥342.3bn |
| Discount Storereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥13m |
| Discount Storereportable segment | segment assets | at 2025-03-31 | ¥152.6bn |
| Discount Storereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥17.9bn |
| Drug Storereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥21.2bn |
| Drug Storereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥11.3bn |
| Drug Storereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥517.3bn |
| Drug Storereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥459.6bn |
| Drug Storereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥57.8bn |
| Drug Storereportable segment | segment assets | at 2025-03-31 | ¥316.9bn |
| Drug Storereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥26.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥35.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥17.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥859.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥801.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥57.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥469.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥44.5bn |
| Drug Storereportable segment | employees | at 2026-03-31 | 4622 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,608
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | Prior1YearInstant | 174293000000 | JPY |
| Liabilities | CurrentYearInstant | 189504000000 | JPY |
| Capital stock | Prior1YearInstant | 3931000000 | JPY |
| Capital stock | CurrentYearInstant | 3931000000 | JPY |
| Capital surplus | Prior1YearInstant | 7533000000 | JPY |
| Capital surplus | CurrentYearInstant | 7577000000 | JPY |
| Retained earnings | Prior1YearInstant | 263754000000 | JPY |
| Retained earnings | CurrentYearInstant | 279859000000 | JPY |
| Treasury stock | Prior1YearInstant | -3868000000 | JPY |
| Treasury stock | CurrentYearInstant | -3843000000 | JPY |
| Shareholders equity | Prior1YearInstant | 271350000000 | JPY |
| Shareholders equity | CurrentYearInstant | 287524000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 17000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 24000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | － | JPY |
| Deferred gains or losses on hedges | CurrentYearInstant | -0 | JPY |
| Revaluation reserve for land | Prior1YearInstant | -1782000000 | JPY |
| Revaluation reserve for land | CurrentYearInstant | -1702000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 128000000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 154000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -1636000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | -1523000000 | JPY |
| Net assets | Prior1YearInstant | 269713000000 | JPY |
| Net assets | CurrentYearInstant | 286001000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 444007000000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 475505000000 | JPY |
| Net sales | Prior1YearDuration | 801811000000 | JPY |
| Net sales | CurrentYearDuration | 842512000000 | JPY |
| Cost of sales | Prior1YearDuration | 597723000000 | JPY |
| Cost of sales | CurrentYearDuration | 626341000000 | JPY |
| Gross profit | Prior1YearDuration | 204087000000 | JPY |
| Gross profit | CurrentYearDuration | 216170000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 0 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | － | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 10000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 2000000 | JPY |
| Salaries allowances and bonuses sga | Prior1YearDuration | 58216000000 | JPY |
| Salaries allowances and bonuses sga | CurrentYearDuration | 62654000000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 711000000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 708000000 | JPY |
| Rent expenses sga | Prior1YearDuration | 33337000000 | JPY |
| Rent expenses sga | CurrentYearDuration | 34884000000 | JPY |
| Depreciation sga | Prior1YearDuration | 17282000000 | JPY |
| Depreciation sga | CurrentYearDuration | 18760000000 | JPY |
| Other sga | Prior1YearDuration | 50031000000 | JPY |
| Other sga | CurrentYearDuration | 52326000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 159591000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 169338000000 | JPY |
| Operating income | Prior1YearDuration | 44496000000 | JPY |
| Operating income | CurrentYearDuration | 46831000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |